首页> 中文期刊> 《中国中医药信息杂志》 >中药抗病毒性心肌炎实验进展

中药抗病毒性心肌炎实验进展

         

摘要

病毒性心肌炎(VMC)是常见的病毒感染导致的心肌炎性病变,目前西医治疗主要以对症支持为主,而临床上运用中医药治疗该病疗效显著.本文主要从VMC常见的4种机制入手,分别阐述中药单体或复方制剂具有抗病毒、调节免疫、抗自由基、抗氧化、改善心肌代谢、保护心肌细胞等作用,为临床上中药的运用提供实验依据.%Viral myocarditis (VMC) is normally caused by myocarditis virus infection. Currently, the Western medicine treatment is mainly about symptomatic supportive treatment, while TCM has remarkable efficacy for this disease. This article started from the 4 common mechanisms of VMC, and elaborated the effects of individual and compound preparation, such as antiviral, regulating immune, anti free redical, antioxidation, improving myocardial metabolism, protecting myocardial cells, with a purpose to provide experimental references for TCM application in clinic.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号